U.S. Markets closed

Veru (VERU) Soars: Stock Adds 6.9% in Session

Zacks Equity Research
·2 min read

Veru Inc. VERU was a big mover last session, as the company saw its shares rise nearly 7% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This stock, which remained volatile and traded within the range of $3.19–$3.74 in the past one-month time frame, witnessed a sharp increase yesterday.

The company has seen two positive estimate revisions in the past few months, while its Zacks Consensus Estimate for the current quarter has also moved higher over the past few months, suggesting that more solid trading could be ahead for Veru. So make sure to keep an eye on this stock going forward to see if this recent jump can turn into more strength down the road.

Veru currently has a Zacks Rank #2 (Buy) while its Earnings ESP is 0.00%.

Veru Inc. Price

Veru Inc. Price
Veru Inc. Price

Veru Inc. price | Veru Inc. Quote

 

A better-ranked stock in the Medical sector is Avenue Therapeutics Inc ATXI, which currently carries a Zacks Rank #1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.

5 Stocks Set to Double

Each was hand-picked by a Zacks expert as the #1 favorite stock to gain +100% or more in 2020. Each comes from a different sector and has unique qualities and catalysts that could fuel exceptional growth.

Most of the stocks in this report are flying under Wall Street radar, which provides a great opportunity to get in on the ground floor.

Today, See These 5 Potential Home Runs >>
 


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
Female Health Company The (VERU) : Free Stock Analysis Report
 
Avenue Therapeutics, Inc. (ATXI) : Free Stock Analysis Report
 
To read this article on Zacks.com click here.
 
Zacks Investment Research